| Literature DB >> 25601159 |
Hong-Jen Lee1, Li Lan2, Guang Peng3, Wei-Chao Chang4, Ming-Chuan Hsu5, Ying-Nai Wang6, Chien-Chia Cheng5, Leizhen Wei2, Satoshi Nakajima2, Shih-Shin Chang1, Hsin-Wei Liao1, Chung-Hsuan Chen7, Martin Lavin8, K Kian Ang9, Shiaw-Yih Lin10, Mien-Chie Hung11.
Abstract
Ataxia telangiectasia mutated (ATM) mediates DNA damage response by controling irradiation-induced foci formation, cell cycle checkpoint, and apoptosis. However, how upstream signaling regulates ATM is not completely understood. Here, we show that upon irradiation stimulation, ATM associates with and is phosphorylated by epidermal growth factor receptor (EGFR) at Tyr370 (Y370) at the site of DNA double-strand breaks. Depletion of endogenous EGFR impairs ATM-mediated foci formation, homologous recombination, and DNA repair. Moreover, pretreatment with an EGFR kinase inhibitor, gefitinib, blocks EGFR and ATM association, hinders CHK2 activation and subsequent foci formation, and increases radiosensitivity. Thus, we reveal a critical mechanism by which EGFR directly regulates ATM activation in DNA damage response, and our results suggest that the status of ATM Y370 phosphorylation has the potential to serve as a biomarker to stratify patients for either radiotherapy alone or in combination with EGFR inhibition.Entities:
Mesh:
Substances:
Year: 2015 PMID: 25601159 PMCID: PMC4650576 DOI: 10.1038/cr.2015.8
Source DB: PubMed Journal: Cell Res ISSN: 1001-0602 Impact factor: 25.617